Loading clinical trials...
Loading clinical trials...
This study is aimed to evaluate safety, tolerability and immunogenicity of three doses of Novartis 4CMenB and of one dose of Novartis Meningococcal ACWY vaccine when administered to healthy at-risk ad...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novartis Vaccines
NCT01725217 · Meningococcal Disease
NCT03694405 · Meningococcal Disease, Invasive
NCT04358731 · Vaccine for Meningococcal Disease
NCT01896596 · Meningococcal Disease, Pneumococcal Disease, and more
NCT02451514 · Meningococcal Disease, Infections, Meningococcal
Azienda USL 7 of Siena
Siena
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions